Eur Rev Med Pharmacol Sci 2020; 24 (22): 11578-11586
DOI: 10.26355/eurrev_202011_23799

Circ_0005273 induces the aggravation of pancreatic cancer by targeting KLF12

Y.-S. Hou, X. Li

Department of GI Medicine, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China. lixudoc666@163.com


OBJECTIVE: The purpose of this study was to explore the potential influences of circ_0005273 and its downstream target KLF12 on the progression of pancreatic cancer.

PATIENTS AND METHODS: Relative levels of circ_0005273 and KLF12 in paired pancreatic cancer tissues and normal tissues were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Then, the differences in clinical indicators and prognosis (overall survival and progression-free survival) between pancreatic cancer patients expressing high and low levels of circ_0005273 were compared. After knockdown of circ_0005273 in AsPC-1 and CFPAC-1 cells, viability and migratory ability were assessed by cell counting kit-8 (CCK-8), transwell and wound healing assays. The regulatory effect of circ_0005273 on KLF12 was determined through Western blotting assay. Finally, the interaction between circ_0005273 and KLF12 was tested by dual-luciferase reporter assay.

RESULTS: It was found that circ_0005273 was upregulated in pancreatic cancer tissues than that in normal tissues. Besides, pancreatic cancer patients expressing a high level of circ_0005273 had higher incidence rates of lymphatic metastasis and distant metastasis, as well as poor prognosis. Knockdown of circ_0005273 weakened the proliferative and migratory abilities of AsPC-1 and CFPAC-1 cells. KLF12 was the target gene binding to circ_0005273, showing a negative expression correlation between each other. Moreover, the protein level of KLF12 was downregulated by knockdown of circ_0005273. KLF12 was able to abolish the regulatory effects of circ_0005273 on the phenotypes of pancreatic cancer cells.

CONCLUSIONS: Circ_0005273 drives proliferative and migratory abilities of pancreatic cancer cells via activating the KLF12, and it is able to predict lymphatic metastasis, distant metastasis and prognosis in pancreatic cancer patients.

Free PDF Download

To cite this article

Y.-S. Hou, X. Li
Circ_0005273 induces the aggravation of pancreatic cancer by targeting KLF12

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11578-11586
DOI: 10.26355/eurrev_202011_23799